ALECENSA
Capsule, hard, 150mg
RxActive license
Active substance (INN)
alectinib
Pharmaceutical form
Pharmaceutical formCapsule, hard
Strength150mg
PackagingUkupno 224 kapsula tvrdih u blisteru (28x8) u kartonskoj kutiji
ManufacturerF. Hoffmann-La Roche AG, Switzerland
Therapeutic groupAntineoplastic and immunomodulating agents (L01ED03)
Marketing authorization holder"Hoffmann-La Roche LTD" D.S.D. Podgorica
Authorization dateSeptember 27, 2024
Source: CInMED register